{"version":"1.0","provider_name":"Harvard Gazette","provider_url":"https:\/\/dev.news.harvard.edu\/gazette","author_name":"harvardgazette","author_url":"https:\/\/dev.news.harvard.edu\/gazette\/story\/author\/harvardgazette\/","title":"Recurrent ovarian cancer patients may have hope &#8212; Harvard Gazette","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"vnBY0LIvWz\"><a href=\"https:\/\/dev.news.harvard.edu\/gazette\/story\/2015\/07\/recurrent-ovarian-cancer-patients-may-have-hope\/\">Recurrent ovarian cancer patients may have hope<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/dev.news.harvard.edu\/gazette\/story\/2015\/07\/recurrent-ovarian-cancer-patients-may-have-hope\/embed\/#?secret=vnBY0LIvWz\" width=\"600\" height=\"338\" title=\"&#8220;Recurrent ovarian cancer patients may have hope&#8221; &#8212; Harvard Gazette\" data-secret=\"vnBY0LIvWz\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/dev.news.harvard.edu\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/dev.news.harvard.edu\/wp-content\/uploads\/2015\/07\/mucinous_lmp_ovarian_tumour_intermed_mag_605.jpg","thumbnail_width":605,"thumbnail_height":403,"description":"Harvard researchers have found a gene therapy that delivers a protein that suppresses the development of female reproductive organs. This new treatment could improve the survival of patients with ovarian cancer that has recurred after chemotherapy. Recurrence happens 70 percent of the time and is invariably fatal."}